(MENAFN Editorial) iCrowdNewswire - Dec 14, 2017
DecisionDatabases recently added the fact-findings of Worldwide RNA Interference Market Report that gives the potential value of the market providing business strategists with the latest growth opportunities covers the complete competitive landscape of the global market with company profiles of key players as all as evaluates the prospective market size, share, trends and growth in the coming years.
RNAi (Ribonucleic Acid Interference) is an RNA-dependent gene silencing process that occurs in live cells to keep a check on the active genes. The major classes of RNAi are micro RNA and small interfering RNA. It is a valuable research tool to selectively induce suppression of genes of interest. RNAi is said to replace the existing recombinant technology in the field of drug discovery and therapeutics.
RNA Interference (RNAi) market is segmented by products, applications, delivery modes, and end users.by products is segmented into design, monitoring/optimizing, and libraries. Based on the libraries, the market is divided into humans, mice, and rats. On the basis of applications, the market is segmented into research and development, therapeutics, drug discovery and development, and agriculture. Based on delivery mode, this market is segmented into vector based, transfection reagents, and electroporation. On the basis of end users, the market is divided into pharmaceutical companies, agriculture based industries, and biotechnology companies. Based on geographies, the market is divided into North America, Europe, Asia, and Rest of World (RoW).
The major factors driving growth of this market are increase in RNA therapeutic development and requirement of lower therapeutic dosages. Inefficiency in RNA drug delivery system is the major restraining factor to this market. Agriculture is an emerging field to use RNAi technology for crop improvement.
Some of the key players in this market are Qiagen N. V., Invitrogen Corporation, Ambion, Inc., Tekmira Pharmaceuticals Corporation, and Merck & Co., Inc.
Get FREE Sample Copy @
DecisionDatabases is involved in providing research reports and company profiles in the global RNA Interference market in terms of revenue and output/volume. Market drivers, opportunities and restraints are thoroughly studied which influences the market. This study is further utilized for the overall analysis of the market. The RNA Interference market is segmented based on the global applications, geographic presence, by products and ingredients. We offer an inclusive category-specific market outlook. We provide access to a comprehensive collection of companies in the industry. The companies can strategize and execute business operations through our competitor analysis. Find the global industry analysis, market size, share, growth, and trends information in our RNA Interference profiles.
Order a Complete RNA Interference Market Research Report @
About Us:
DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics. DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.
Our expert research analysts have been trained to map client's research requirements to the correct research resource leading to a distinctive edge over its competitors. We provide intellectual, precise and meaningful data at a lightning speed.
Contact Information: 3rd Floor, Fountain chambers,
Nanabhai Lane, Fort, Mumbai - 1
E-Mail:
Phone: +91 99 28 237112
Web: www.decisiondatabases.com
MENAFN1412201700703403ID1096231666